CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Net sales	$ 7,084	$ 5,936	$ 6,631
Cost of sales	4,360	3,880	4,086
Gross margin	2,724	2,056	2,545
Selling, general and administrative expenses	364	320	289
Asset impairment	76	0	0
U.K. operations restructuring	23	0	10
Acquisition and integration costs	0	4	39
Other operating—net	(25)	(10)	(31)
Total other operating costs and expenses	438	314	307
Equity in earnings (loss) of operating affiliate	14	4	(8)
Operating earnings	2,300	1,746	2,230
Interest expense	155	121	150
Interest income	(81)	(123)	(158)
Loss on debt extinguishment	6	0	0
Other non-operating—net	(19)	(14)	(10)
Earnings before income taxes	2,239	1,762	2,248
Income tax provision	441	285	410
Net earnings	1,798	1,477	1,838
Less: Net earnings attributable to noncontrolling interests	343	259	313
Net earnings attributable to common stockholders	$ 1,455	$ 1,218	$ 1,525
Net earnings per share attributable to common stockholders:
Basic	$ 8.98	$ 6.75	$ 7.89
Diluted	$ 8.97	$ 6.74	$ 7.87
Weighted-average common shares outstanding:
Basic	162.1	180.4	193.3
Diluted	162.2	180.7	193.8

This item represents the entity's proportionate share for the period of the net income (loss) of its operating investees (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investees at the date of investment.

No definition available.